Results 151 to 160 of about 168,078 (280)

Hepatitis B Vaccine Response in Children of Vaccinated Versus Unvaccinated Mothers: A Retrospective Cohort Study. [PDF]

J Viral Hepat
Shibli S, Suki M, Korzom T, Green MS, Safadi R.   +4 more
europepmc   +1 more source

A randomized prospective study of neonatal hepatitis B vaccine immunogenicity in The Gambia and Papua New Guinea. [PDF]

J Allergy Clin Immunol Glob
Diray-Arce J, Syphurs C, Hoch A, McEnaney K, Smolen KK, Wariri O, Imam A, Dibassey T, Cole F, Ceesay F, Darboe A, Pomat WS, Ford R, Masiria G, Joseph D, Jude J, Ben-Othman R, Shannon CP, Thomas S, Leroux-Roels G, Clement F, Waerlop G, McLoughlin C, Vignolo SM, Rao S, Amenyogbe N, EPIC Consortium, Odumade O, Angelidou A, Tebbutt SJ, Marchant A, Kollmann TR, Levy O, Richmond PC, van den Biggelaar AHJ, Kampmann B, Idoko OT, Ozonoff A.   +37 more
europepmc   +1 more source

SARS‐CoV‐2 targets mitochondria, exacerbating COVID‐19 pneumonia

The Journal of Physiology, EarlyView.
Abstract figure legend Following entry into airway epithelial cells (AECs), SARS‐CoV‐2 releases its single‐stranded RNA into the cytoplasm, where it is translated into viral proteins. Several of these viral proteins localize to mitochondria and interact with key mitochondrial components.
Danchen Wu, Asish Dasgupta, Jaskaran Singh Hora, Kuang‐Hueih Chen, Arinjay Banerjee, Stephen L. Archer   +5 more
wiley   +1 more source

Institutional drivers of newborn hepatitis B vaccine disparities: A multi-hospital analysis in Washington, DC, 2017-2023. [PDF]

Hum Vaccin Immunother
Leslie TF, Delamater PL, Abutaleb AO, Yang YT.   +3 more
europepmc   +1 more source

Targeting Middle East Respiratory Syndrome Coronavirus Spike Fusion Machinery With Antiviral Peptides: In Silico Exploration of the Heptad Repeat 2 Domain

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
Griffithsin, Brevinin‐2, and CCL20 were identified as potent MERS‐CoV fusion inhibitor candidates targeting the HR2 domain through integrated molecular docking, MD simulations, and MM/PBSA analyses. These peptides demonstrated superior binding stability and favorable safety profiles compared to the standard inhibitor, supporting their potential as ...
Nasser Alotaiq, Doni Dermawan, Samir Chtita   +2 more
wiley   +1 more source

Oral Microbiome Resilience During SARS‐CoV‐2 Infection and Diversity Shifts After COVID‐19 Vaccination in a Hispanic Population

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
The oral microbiome in Hispanics remains largely resilient during mild SARS‐CoV‐2 infection, showing minimal diversity changes, while COVID‐19 vaccination induces increased microbial evenness and compositional shifts. These findings highlight limited infection impact but suggest vaccination transiently reshapes oral microbial ecology.
Daniela Vargas‐Robles, Jean L. Santos Agrait, Jaleniz Suárez‐Pérez, Frances Vázquez, Anelisse Dominicci‐Maura, Carlos A. Sariol, Carmen Zorrilla, Josefina Romaguera, Filipa Godoy‐Vitorino   +8 more
wiley   +1 more source

Evaluation of hepatitis B vaccine effectiveness among fully vaccinated healthcare workers in Ethiopia. [PDF]

BMC Infect Dis
Adugna A, Amare GA, Muche Y, Getinet M, Melkamu A, Dilnessa T, Malik T, Belew H, Jemal M, Abebaw D.   +9 more
europepmc   +1 more source

Investigating the role of a conserved hydrophobic pocket of gp41 in the anti‐HIV activity of fusion inhibitors

Protein Science, Volume 35, Issue 6, June 2026.
Abstract Membrane fusion between HIV and host cells requires interaction between the N‐terminal and C‐terminal repeat regions (NHR and CHR) of the gp41 envelope subunit. A deep hydrophobic pocket (HP) on the surface of NHR is considered crucial in this interaction.
Daniel Polo‐Megías, Mario Cano‐Muñoz, Laura Sánchez‐Martínez, Sara Lestani, Christiane Moog, Thomas Decoville, María Carmen Salinas‐García, José Antonio Gavira, Ana Cámara‐Artigas, Francisco Conejero‐Lara   +9 more
wiley   +1 more source

Public Health Achievements in Rwanda: A 21st Century Transformation

Public Health Challenges, Volume 5, Issue 2, June 2026.
This narrative review examines Rwanda's post‐2000 public health transformation using the WHO health system building blocks. It shows how strategic governance, universal health coverage via mutuelle de santé, community health workers, and digital health tools have driven substantial gains in maternal/child health, infectious disease control, and ...
Niyibizi Julius, Mugisha John, Nizeyimana Emmanuel   +2 more
wiley   +1 more source

Hepatitis B vaccine immunity in healthcare workers: Seroprotection and cellular immune signatures of waning response. [PDF]

J Family Med Prim Care
Khargekar NC, Pujari V, Athalye S, Mallik A, Jodhawat N, Shinde S, Banerjee A.   +6 more
europepmc   +1 more source